SCIENTURE HOLDINGS INC(NASDAQ:SCNX) stock Fundamental Analysis

Fundamental Rating

SCNX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 37 industry peers in the Health Care Technology industry. SCNX may be in some trouble as it scores bad on both profitability and health. SCNX does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

SCNX had positive earnings in the past year.

SCNX had a negative operating cash flow in the past year.

In the past 5 years SCNX reported 4 times negative net income.

In the past 5 years SCNX always reported negative operating cash flow.

1.2 Ratios

SCNX has a Return On Assets of 8.65%. This is amongst the best in the industry. SCNX outperforms 94.59% of its industry peers.

SCNX's Return On Equity of 11.47% is amongst the best of the industry. SCNX outperforms 94.59% of its industry peers.

		Industry Rank	Sector Rank
ROA	8.65%
ROE	11.47%
ROIC	N/A

ROA(3y)-75.75%

ROA(5y)-69.08%

ROE(3y)-1244.95%

ROE(5y)-781.05%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With an excellent Profit Margin value of 6631.89%, SCNX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.

SCNX has a worse Gross Margin (4.39%) than 81.08% of its industry peers.

In the last couple of years the Gross Margin of SCNX has declined.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	6631.89%
GM	4.39%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-54.95%

GM growth 5Y-41.74%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

SCNX does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, SCNX has more shares outstanding

The number of shares outstanding for SCNX has been increased compared to 5 years ago.

SCNX has a better debt/assets ratio than last year.

2.2 Solvency

SCNX has an Altman-Z score of -0.72. This is a bad value and indicates that SCNX is not financially healthy and even has some risk of bankruptcy.

The Altman-Z score of SCNX (-0.72) is comparable to the rest of the industry.

A Debt/Equity ratio of 0.04 indicates that SCNX is not too dependend on debt financing.

With a Debt to Equity ratio value of 0.04, SCNX perfoms like the industry average, outperforming 59.46% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.04
Debt/FCF	N/A
Altman-Z	-0.72

ROIC/WACCN/A

WACC10.09%

2.3 Liquidity

A Current Ratio of 0.80 indicates that SCNX may have some problems paying its short term obligations.

SCNX's Current ratio of 0.80 is on the low side compared to the rest of the industry. SCNX is outperformed by 72.97% of its industry peers.

SCNX has a Quick Ratio of 0.80. This is a bad value and indicates that SCNX is not financially healthy enough and could expect problems in meeting its short term obligations.

SCNX has a worse Quick ratio (0.80) than 67.57% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.8
Quick Ratio	0.8

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

SCNX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 160.70%, which is quite impressive.

SCNX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -98.47%.

The Revenue for SCNX have been decreasing by -55.05% on average. This is quite bad

EPS 1Y (TTM)160.7%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%94.19%

Revenue 1Y (TTM)-98.47%

Revenue growth 3Y-76.01%

Revenue growth 5Y-55.05%

Sales Q2Q%-97.74%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 0.07, which indicates a rather cheap valuation of SCNX.

Based on the Price/Earnings ratio, SCNX is valued cheaper than 100.00% of the companies in the same industry.

When comparing the Price/Earnings ratio of SCNX to the average of the S&P500 Index (26.60), we can say SCNX is valued rather cheaply.

		Industry Rank	Sector Rank
PE	0.07
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

SCNX has a Yearly Dividend Yield of 168.35%, which is a nice return.

The stock price of SCNX dropped by -67.06% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.

Compared to an average industry Dividend Yield of 36.74, SCNX pays a better dividend. On top of this SCNX pays more dividend than 100.00% of the companies listed in the same industry.

Compared to an average S&P500 Dividend Yield of 2.36, SCNX pays a better dividend.

		Industry Rank	Sector Rank
Dividend Yield	168.35%

5.2 History

SCNX does not have a reliable dividend history as it only pays dividend since a couple or years.

Dividend Growth(5Y)N/A

Div Incr Years0

Div Non Decr Years0

5.3 Sustainability

163.90% of the earnings are spent on dividend by SCNX. This is not a sustainable payout ratio.

DP163.9%

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

SCIENTURE HOLDINGS INC

NASDAQ:SCNX (5/20/2025, 8:00:02 PM)

After market: 0.9141 -0.01 (-0.76%)

0.9211

-0.03 (-2.94%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Technology

Earnings (Last)04-21 2025-04-21/amc

Earnings (Next)06-24 2025-06-24

Inst Owners1.85%

Inst Owner Change18.21%

Ins Owners33.22%

Ins Owner ChangeN/A

Market Cap11.53M

Analysts82.86

Price TargetN/A

Short Float %1.5%

Short Ratio0.04

Dividend

		Industry Rank	Sector Rank
Dividend Yield	168.35%

Yearly Dividend3.08

Dividend Growth(5Y)N/A

DP163.9%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-97.69%

Min Revenue beat(2)-97.95%

Max Revenue beat(2)-97.43%

Revenue beat(4)0

Avg Revenue beat(4)-98.64%

Min Revenue beat(4)-100%

Max Revenue beat(4)-97.43%

Revenue beat(8)1

Avg Revenue beat(8)-52.23%

Revenue beat(12)3

Avg Revenue beat(12)-32.85%

Revenue beat(16)6

Avg Revenue beat(16)-21.1%

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	0.07
Fwd PE	N/A
P/S	84.36
P/FCF	N/A
P/OCF	N/A
P/B	0.15
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)12.78

EY1387.47%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-1.34

FCFYN/A

OCF(TTM)-1.14

OCFYN/A

SpS0.01

BVpS6.32

TBVpS-1.49

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	8.65%
ROE	11.47%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	6631.89%
GM	4.39%
FCFM	N/A

ROA(3y)-75.75%

ROA(5y)-69.08%

ROE(3y)-1244.95%

ROE(5y)-781.05%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-54.95%

GM growth 5Y-41.74%

F-Score3

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0.04
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	4704.12%
Cap/Sales	1837.6%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.8
Quick Ratio	0.8
Altman-Z	-0.72

F-Score3

WACC10.09%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)160.7%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%94.19%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-98.47%

Revenue growth 3Y-76.01%

Revenue growth 5Y-55.05%

Sales Q2Q%-97.74%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-89.99%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-709.09%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-587.94%

OCF growth 3YN/A

OCF growth 5YN/A

SCIENTURE HOLDINGS INC (SCNX) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens